Search Count: 129
 |
Dife-Sulerythin_E126D O2-Reacted
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2026-06-10 Classification: OXIDOREDUCTASE Ligands: FE, FE2, CL, BU3, PER |
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION
Release Date: 2026-06-10
Ligands: FE, FE2, CL, BU3, PER
 |
Dife-Sulerythin_E53D:E126D O2-Reacted
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-10 Classification: OXIDOREDUCTASE Ligands: BU3, FE, CL, O, PEG, PER |
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION
Release Date: 2026-06-10
Ligands: BU3, FE, CL, O, PEG, PER
 |
Dife-Sulerythin_E126A O2-Reacted
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2026-06-10 Classification: OXIDOREDUCTASE Ligands: FE2, CL, BU3, PER, O |
Organism: Sulfurisphaera tokodaii str. 7
Method: X-RAY DIFFRACTION
Release Date: 2026-06-10
Ligands: FE2, CL, BU3, PER, O
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinazoline-Based Inhibitor 1Q
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: A1JUO, DMS, EDO, BU3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-20
Ligands: A1JUO, DMS, EDO, BU3
 |
Proteinmpnn Mutated Pf3D7_1475600 (Pfbdp4-Brd, 77.8% Sequence Identity) In Complex With Gsk9311
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2026-05-13 Classification: TRANSCRIPTION Ligands: 8VI, EDO, BU3 |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2026-05-13
Ligands: 8VI, EDO, BU3
 |
Proteinmpnn Mutated Krep Domain Of Pf3D7_1343700 (Pfk13-Krep, 59,4% Sequence Identity)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2026-05-13 Classification: UNKNOWN FUNCTION Ligands: BU3, EDO, TRS |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2026-05-13
Ligands: BU3, EDO, TRS
 |
E2S Domain Of Hev Orf2 Type 4
Organism: Hepatitis e virus genotype 1 (isolate human/burma)
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2026-01-14 Classification: VIRAL PROTEIN Ligands: SO4, BU3 |
Organism: Hepatitis e virus genotype 1 (isolate human/burma)
Method: X-RAY DIFFRACTION
Release Date: 2026-01-14
Ligands: SO4, BU3
 |
Mutant G490N/V492M Of Hev-1 E2S Domain
Organism: Hepatitis e virus genotype 1 (isolate human/burma)
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2026-01-14 Classification: VIRAL PROTEIN Ligands: SO4, BU3 |
Organism: Hepatitis e virus genotype 1 (isolate human/burma)
Method: X-RAY DIFFRACTION
Release Date: 2026-01-14
Ligands: SO4, BU3
 |
1-Epi-Cubenol Synthase From Nonomuraea Coxensis (Ncecs) In Complex With 2,3-Dhfpp
Organism: Nonomuraea coxensis
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-12-24 Classification: LYASE Ligands: 3E9, MG, BU3, NA |
Organism: Nonomuraea coxensis
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: 3E9, MG, BU3, NA
 |
T-Muurolol Synthase From Roseiflexus Castenholzii (Tms) In Complex With 2,3-Dhfpp [P4(3)2(1)2(1)]
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-24 Classification: LYASE Ligands: MG, 3E9, BU3, EDO, GOL |
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: MG, 3E9, BU3, EDO, GOL
 |
T-Muurolol Synthase From Roseiflexus Castenholzii (Tms) In Complex With Converted 1,2-Dhnpp (Compound 1)
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-12-24 Classification: LYASE Ligands: MG, POP, FAR, BU3, EDO |
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: MG, POP, FAR, BU3, EDO
 |
T-Muurolol Synthase From Roseiflexus Castenholzii (Tms) In Complex With Converted 10,11-Dhfpp (Compound 2+)
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2025-12-24 Classification: LYASE Ligands: MG, POP, A1IW0, BU3, EDO |
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: MG, POP, A1IW0, BU3, EDO
 |
T-Muurolol Synthase From Roseiflexus Castenholzii (Tms) In Complex With Converted 6,7-Dhfpp (Compound 3+)
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-24 Classification: LYASE Ligands: MG, POP, A1IWZ, BU3, EDO, MES |
Organism: Roseiflexus castenholzii
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: MG, POP, A1IWZ, BU3, EDO, MES
 |
Crystal Structure Of Human Sirt2 In Complex With The Covalent Adduct Of Sirreal-Triazole Inhibitor Mz242 And Adp-Ribose
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.10 Å Release Date: 2025-11-12 Classification: HYDROLASE Ligands: A1JK7, BU3, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-11-12
Ligands: A1JK7, BU3, ZN
 |
Crystal Structure Of Human Sirt2 In Complex With Sirreal-Triazole Inhibitor Sh10
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-11-12 Classification: HYDROLASE Ligands: ZN, BU3, EDO, A1JK0 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-11-12
Ligands: ZN, BU3, EDO, A1JK0
 |
Crystal Structure Of Human Sirt2 In Complex With Sirreal-Triazole Inhibitor Lg023
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-11-12 Classification: HYDROLASE Ligands: ZN, A1JK1, BU3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-11-12
Ligands: ZN, A1JK1, BU3
 |
Crystal Structure Of Human Sirt3 In Complex With The Covalent Adduct Of Peptide Triazole Inhibitor Ltdi1 And Adp-Ribose
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2025-11-12 Classification: HYDROLASE Ligands: ZN, BU3, A1JK8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-11-12
Ligands: ZN, BU3, A1JK8
 |
Crystal Structure Of The Oxidized Respiratory Complex I Subunit Nuoef From Aquifex Aeolicus, Double Mutation V90P And V136M(Nuoe), Bound To Nad+
Organism: Aquifex aeolicus vf5
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2025-11-05 Classification: OXIDOREDUCTASE Ligands: FES, SF4, FMN, NAD, NA, BU3, CL |
Organism: Aquifex aeolicus vf5
Method: X-RAY DIFFRACTION
Release Date: 2025-11-05
Ligands: FES, SF4, FMN, NAD, NA, BU3, CL
 |
Crystal Structure Of The Leishmania Bromodomain Lmxbdf5.1 In Complex With Oxfbd06
Organism: Leishmania mexicana
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2025-09-03 Classification: TRANSCRIPTION Ligands: A1IMI, BU3, K |
Organism: Leishmania mexicana
Method: X-RAY DIFFRACTION
Release Date: 2025-09-03
Ligands: A1IMI, BU3, K
 |
Crystal Structure Of Crebbp Bromodomain In Complex With (R,E)-2-Methyl-1,2,3,5,10,11,17,18,21,22-Decahydro-4H,16H,20H-13,15-Etheno-7,25-(Metheno)[1,4]Diazepino[2,3-H]Pyrido[1,2-P][1]Oxa[4,16]Diazacyclononadecine-4,8(9H)-Dione
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2025-08-20 Classification: TRANSFERASE Ligands: BU3, A1IKL, CIT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: BU3, A1IKL, CIT